Showing results (1031-1040 of 1,104) with videos related to
Sort By:
Pageof 111
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 10, 2023
Identification of Sodium- and Chloride-Sensitive Sites in the Slack ChannelJie Xu, Yan-Tian Lv, Xiao-Yun Zhao, et al.Prostate Cancer and Prostatic Diseases|July 17, 2024
Body composition as a determinant of the therapeutic index with androgen signaling inhibitionAndrew W Hahn, Rebecca S Tidwell, Patrick G Pilie, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2016
Randomized, Double-Blind, Phase III Trial of Ipilimumab Versus Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naive Castration-Resistant Prostate CancerTomasz M Beer, Eugene D Kwon, Charles G Drake, et al.Iscience|June 11, 2020
Urothelial-to-Neural Plasticity Drives Progression to Small Cell Bladder CancerGuoliang Yang, Jolanta Bondaruk, David Cogdell, et al.Cell Reports|April 6, 2022
Mesenchymal and stem-like prostate cancer linked to therapy-induced lineage plasticity and metastasisHyunho Han, Yan Wang, Josue Curto, et al.Cancer Research|January 30, 2014
PCAT-1, a long noncoding RNA, regulates BRCA2 and controls homologous recombination in cancerJohn R Prensner, Wei Chen, Matthew K Iyer, et al.JAMA Network Open|August 30, 2021
Evaluation of Technology-Enabled Monitoring of Patient-Reported Outcomes to Detect and Treat Toxic Effects Linked to Immune Checkpoint InhibitorsPavlos Msaouel, Clara Oromendia, Arlene O Siefker-Radtke, et al.Biomarker Research|November 10, 2024
Validation of a prognostic blood-based sphingolipid panel for men with localized prostate cancer followed on active surveillanceJustin R Gregg, Lisa Newcomb, Ranran Wu, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 31, 2004
Eligibility and outcomes reporting guidelines for clinical trials for patients in the state of a rising prostate-specific antigen: recommendations from the Prostate-Specific Antigen Working GroupHoward I Scher, Mario Eisenberger, Anthony V D'Amico, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 2014
Cabozantinib in chemotherapy-pretreated metastatic castration-resistant prostate cancer: results of a phase II nonrandomized expansion studyMatthew R Smith, Christopher J Sweeney, Paul G Corn, et al.Pageof 111